Tanabe/Taisho integrate operations
Executive Summary
Tanabe Seiyaku and Taisho Pharmaceutical will consolidate their pharmaceutical and OTC drug operations under a new holding company, to be headed by Tanabe President Toshio Tanaka. The move appears to take Tanabe out of the pool of potential pharmaceutical acquisition targets in Japan. The businesses will be integrated Oct. 1 and the holding company will be founded on April 1. Combined sales will be approximately $4 bil. in 2002